Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Runnebaum

Showing results (371-380 of 452) with videos related to

Pageof 46
Sort By:
European Radiology|June 5, 2008
Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative studyDiane M Renz, Pascal A T Baltzer, Joachim Böttcher, et al.
Plos One|March 21, 2014
A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive womenAlfred Hansel, Daniel Steinbach, Christiane Greinke, et al.
Academic Radiology|January 22, 2008
Inflammatory breast carcinoma in magnetic resonance imaging: a comparison with locally advanced breast cancerDiane M Renz, Pascal A T Baltzer, Joachim Böttcher, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2014
Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rateJ Vorwergk, M P Radosa, K Nicolaus, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 30, 1999
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelinM Sillem, M Parviz, H W Woitge, et al.
Carcinogenesis|May 24, 2011
An integrative functional genomic and gene expression approach revealed SORBS2 as a putative tumour suppressor gene involved in cervical carcinogenesisClaudia Backsch, Bettina Rudolph, Daniel Steinbach, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2014
Long-term risk of fibroid recurrence after laparoscopic myomectomyM P Radosa, Z Owsianowski, A Mothes, et al.
Clinical Epigenetics|January 23, 2021
CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patientsKarolin Heinze, Matthias Rengsberger, Mieczyslaw Gajda, et al.
Anticancer Research|November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)D G Kieback, M F Press, E N Atkinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2008
Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumorsM Gajda, O Camara, S Oppel, et al.
Pageof 46

Showing results (371-380 of 452) with videos related to

Sort By:
Pageof 46
European Radiology|June 5, 2008
Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative studyDiane M Renz, Pascal A T Baltzer, Joachim Böttcher, et al.
Plos One|March 21, 2014
A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive womenAlfred Hansel, Daniel Steinbach, Christiane Greinke, et al.
Academic Radiology|January 22, 2008
Inflammatory breast carcinoma in magnetic resonance imaging: a comparison with locally advanced breast cancerDiane M Renz, Pascal A T Baltzer, Joachim Böttcher, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2014
Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rateJ Vorwergk, M P Radosa, K Nicolaus, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 30, 1999
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelinM Sillem, M Parviz, H W Woitge, et al.
Carcinogenesis|May 24, 2011
An integrative functional genomic and gene expression approach revealed SORBS2 as a putative tumour suppressor gene involved in cervical carcinogenesisClaudia Backsch, Bettina Rudolph, Daniel Steinbach, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2014
Long-term risk of fibroid recurrence after laparoscopic myomectomyM P Radosa, Z Owsianowski, A Mothes, et al.
Clinical Epigenetics|January 23, 2021
CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patientsKarolin Heinze, Matthias Rengsberger, Mieczyslaw Gajda, et al.
Anticancer Research|November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)D G Kieback, M F Press, E N Atkinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2008
Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumorsM Gajda, O Camara, S Oppel, et al.
Pageof 46